RE: Results18 Nov 2021 07:17
I guess the placing would depend on whether the dispute is settled and also orders based on the tests they are in the final stages of TT
"Currently in the process of transferring two COVID-19 Antigen tests into routine manufacture - Avacta plc's AffiDx® SARS-CoV-2 lateral flow test, and Vatic Health's KnowNow™ saliva COVID-19 antigen test"
also high capacity now in place
" we have invested heavily in expanding our manufacturing facilities in order to meet the growing demand for lateral flow tests, with our current manufacturing capacity now totalling 150 million tests in card format and 85 million foiled device format per year."